| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/07/1990 | EP0356724A2 Method of increasing the quantity of product produced by fragile cell and tissue cultures |
| 03/07/1990 | EP0356450A1 Diagnostics and vaccines for mycobacteria in public health, medical and veterinary practice |
| 03/07/1990 | CN1040205A Cytotoxic drug conjugates |
| 03/07/1990 | CN1040204A Cytotoxic drug conjugates |
| 03/06/1990 | US4906742 Encoding antigens of M. Leprae |
| 03/06/1990 | US4906734 Human conglutinin |
| 03/06/1990 | US4906715 N,N'-divinylalkylurea crosslinked polymers, a process for their preparation, and their use |
| 03/06/1990 | US4906564 Antigenic determinants recognized by antibodies obtained using a pathogenic agent or a derivative thereof that presents a restricted set of antigens |
| 03/06/1990 | US4906469 Appropriate cytotoxic pharmaceutical combination especially for the treatment of cancers |
| 03/06/1990 | US4906452 Trichothecene conjugates and methods of use |
| 03/01/1990 | DE3828582A1 Monoklonaler antikoerper zur inhibierung der infektion von zellen durch hiv-viren A monoclonal antibody to inhibit the infection of cells by HIV viruses |
| 02/28/1990 | EP0356409A2 A method for the production and isolation of a fusion protein in eukaryotic cells |
| 02/28/1990 | EP0356397A2 Monoclonal antibodies against, and cell surface antigen of, lung carcinoma |
| 02/28/1990 | EP0356339A1 Influenza vaccine and novel adjuvants |
| 02/28/1990 | EP0356007A2 Antigenic determinants |
| 02/28/1990 | EP0355140A1 Human monoclonal anti-hiv-i-antibodies |
| 02/28/1990 | EP0355097A1 Substituted cyclic complex-forming substances, complexes and complex salts, process for manufacturing same, and pharmaceutical agents which contain them |
| 02/28/1990 | CN1040053A Expression of hepatitis b pres2 protein in methylotrophic yeasts |
| 02/27/1990 | US4904596 Medical diagnosis |
| 02/27/1990 | US4904481 Method of conferring immuno-tolerance to a specific antigen |
| 02/27/1990 | US4904468 Canine coronavirus vaccine |
| 02/27/1990 | US4903635 High speed automated injection system for avian embryos |
| 02/27/1990 | CA1266243A1 Method and cell line for continuous production of retroviruses (htlv-iii) related to aids |
| 02/27/1990 | CA1266234A1 Method of binding microflora |
| 02/27/1990 | CA1266232A1 Method of conferring immuno-tolerance to a specific antigen |
| 02/22/1990 | WO1990001556A1 In vivo infection of live insects with a recombinant baculovirus |
| 02/22/1990 | WO1990001549A2 Gene encoding protein antigens of plasmodium falciparum |
| 02/22/1990 | WO1990001547A1 Methods for isolating herpes virus thymidine kinase-encoding dna |
| 02/22/1990 | WO1990001546A1 Equine herpesvirus-1 vaccine |
| 02/22/1990 | WO1990001497A1 IMMUNOGENIC GLYCOPROTEINS OF HUMAN CYTOMEGALOVIRUS gCII |
| 02/22/1990 | WO1990001496A1 Polypeptides and dna encoding same |
| 02/22/1990 | WO1990001495A1 Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
| 02/22/1990 | WO1990001494A1 Polypeptide pertussis toxin vaccine |
| 02/22/1990 | WO1990001339A1 Detection and treatment of infectious and inflammatory lesions |
| 02/22/1990 | WO1990001337A1 Vaccine |
| 02/22/1990 | WO1990001336A1 Novel infectious bursal disease virus |
| 02/22/1990 | WO1990001253A1 Aloe compositions and uses thereof |
| 02/21/1990 | EP0355067A1 Pharmaceutical products for anti-neoplastic therapy |
| 02/21/1990 | EP0354930A1 Pharmaceutical presentation potentializing the cytotrophic effect of animal and/or human sera and/or antitissue antibodies |
| 02/21/1990 | EP0171397B1 Therapeutic agent for combating infections caused by herpes viruses |
| 02/21/1990 | EP0139734B1 Process for determining antigen/antibody complexes |
| 02/20/1990 | US4902783 Adsorption with silica gel, adsorption with activated carbon, density gradient centrifuging and equilibrium density gradient centrifuging |
| 02/20/1990 | US4902618 Production of hybridoma antibodies for interferon |
| 02/20/1990 | US4902616 Process for the preparation of capsular polysaccharides of staphylococci, the polysaccharides obtained, uses of these polysaccharides and strains for carrying out of the process |
| 02/20/1990 | US4902506 Immunogenic conjugates |
| 02/20/1990 | US4902500 Polyoxypropylene-polyoxyethylene block polymer and phospholipid |
| 02/14/1990 | EP0354729A2 Cytotoxic drug conjugates |
| 02/14/1990 | EP0354728A2 Cytotoxic drug conjugates |
| 02/14/1990 | EP0354628A1 Vaccine suitable for prophylaxis and control, respectively, of the pig disease caused by Haemophilus pleuropneumoniae as well as a method for its production |
| 02/14/1990 | EP0354611A1 Synthtic antigens useful in the diagnosis of malaria induced by plasmodium vivax |
| 02/14/1990 | EP0354440A1 Human Papilloma virus type 57, its DNA and proteins encoded thereby |
| 02/14/1990 | EP0354408A1 Anti-urokinase monoclonal antibodies |
| 02/14/1990 | EP0354213A1 Transgenic animal cells resistant to viral infection |
| 02/13/1990 | USRE33164 Influenza vaccine production in liquid cell culture |
| 02/13/1990 | US4900747 Method and agents for removing advanced glycosylation endproducts |
| 02/13/1990 | US4900720 Plasmapheresis |
| 02/13/1990 | US4900675 Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-β-aldoglycosidyl) derivatives |
| 02/13/1990 | US4900549 Process for preparing immunogenic complexes and pharmaceutical composition containing these complexes |
| 02/13/1990 | US4900548 Aids treatment |
| 02/13/1990 | US4900547 Method to immunize mammals against tumors |
| 02/13/1990 | CA1265742A1 Process for the detection of the presence of an allergy and for the specific detection of the allergen responsible for the allergy |
| 02/08/1990 | WO1990001066A1 Porcine polyclonal and monoclonal antibodies |
| 02/08/1990 | WO1990001039A1 Nonglycosylated human interleukin-3 compositions |
| 02/08/1990 | WO1990000903A1 Method and compositions for the treatment and prevention of septic shock |
| 02/08/1990 | WO1990000902A1 Monoclonal antibodies reactive with cachectin |
| 02/08/1990 | WO1990000901A1 Synthetic vaccine against aids virus |
| 02/08/1990 | WO1989009788A3 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 02/08/1990 | WO1989009787A3 Osteogenic devices |
| 02/07/1990 | EP0354109A1 Recombinant HBsAg hybrid particles having morphological characteristics of the HBsAg antigen and containing an immunogenic sequence which induces neutralizing antibodies directed against HIV or susceptible of being recognized by such antibodies. Nucleotide sequences coding for such particles and vaccines containing them |
| 02/07/1990 | EP0354072A1 Precursors of the HIV-2 retrovirus envelope glycoprotein and related antigens |
| 02/07/1990 | EP0353960A2 Polyspecific anti-leukocyte conjugate for detection and treatment of infectious and inflammatory lesions |
| 02/07/1990 | EP0353851A1 Fowlpox virus non-essential regions |
| 02/07/1990 | EP0353823A1 Immunologically active peptide conjugate PPD-(NANP)n useful as an antimalaria vaccine |
| 02/07/1990 | EP0353809A1 Pseudorabies virus vaccine |
| 02/07/1990 | EP0353450A1 Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates |
| 02/07/1990 | CN1039359A Ibdv production in continuous lines |
| 02/06/1990 | US4898815 Diagnostic serum from rabbit treated with polypeptide kit to detect cholera or escherichia |
| 02/06/1990 | US4898730 Method to stimulate the immune response to specific antigens |
| 02/06/1990 | CA1265648A1 Leukemia-associated virus immunogen, vaccine and assay |
| 02/06/1990 | CA1265448A1 Process for preparing hepatitis b surface antigen containing particles in novel forms which are highly immunogenic |
| 02/06/1990 | CA1265447A1 Hepatitis b antigenic compositions and vaccines against hepatitis b derived therefrom |
| 01/31/1990 | EP0353111A1 Nucleic acid or fragments thereof encoding the P30 protein of Toxoplasma gondii, methods for their preparation and uses thereof |
| 01/31/1990 | EP0353108A1 Process for stabilizing vaccines and associations of attenuated lyophilized viral vaccines, and compositions obtained |
| 01/31/1990 | EP0352835A1 IBDV production in continuous cell lines |
| 01/31/1990 | EP0352766A2 Synthesis of glycosphingolipid derivates for use in the preparation of immuno- and affinity adsorbents to be used in the purification of antibodies and specific toxins, and for diagnostic use |
| 01/31/1990 | EP0352761A2 Antigens composed of "major histocompatibility complex" class I antigens and specific carrier molecules, their production and use |
| 01/31/1990 | EP0352500A2 Method for the production of a polyclonal immunoglobulin-based intravenous preparation with a high IgM content . |
| 01/31/1990 | EP0352328A1 Human monoclonal antibody against aspergilli |
| 01/30/1990 | US4897464 Purified protein having angiogenic activity and methods of preparation |
| 01/30/1990 | US4897354 Monoclonal antibody-specific merozoite antigens |
| 01/30/1990 | US4897265 Method for treating disorders of the vascular and pulmonary systems |
| 01/30/1990 | US4897264 Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody |
| 01/30/1990 | CA1265054A1 Vaccine for generating an immunogenic t cell response protective against a virus |
| 01/30/1990 | CA1265051A1 Pasteurized, isoagglutinin-free factor viii preparation and a process for its production |
| 01/25/1990 | WO1990000617A1 Antibodies specific towards gp 48 |
| 01/25/1990 | WO1990000609A1 Cellulose binding fusion proteins |
| 01/25/1990 | WO1990000604A1 Transformed shigella |
| 01/25/1990 | WO1990000597A1 Post-transfusion, non-a, non-b hepatitis virus and antigens |
| 01/25/1990 | WO1990000594A2 Recombinant mycobacterial expression vehicles and uses therefor |
| 01/25/1990 | WO1990000569A1 Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex |